Radboud University Medical Center: HIV Infections trials

The registry lists 14 HIV Infections studies with Radboud University Medical Center as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 7Phase 2 4No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.RecruitingNCT00825929
• The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor DoravirineStatus unknownNCT05536466Not applicable
• 2000 HIV Human Functional Genomics Partnership ProgramCompletedNCT03994835
• Pharmacokinetics of Once Daily Darunavir/Ritonavir in HIV-infected ChildrenCompletedNCT02285478
• Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor RaltegravirCompletedNCT01288417Phase 1
• The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)CompletedNCT01246804Phase 1
• The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine ResistanceCompletedNCT01187719Phase 2
• Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)CompletedNCT00977301Phase 1
• Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected PatientsCompletedNCT00943540Phase 2
• Pharmacokinetic Study of Two Generic Co-formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)CompletedNCT00665951Phase 1
• The Influence of Raltegravir on Pravastatin Pharmacokinetics(GRAPPA)CompletedNCT00665717Phase 1
• Pharmacokinetic Study on Raltegravir and LamotrigineCompletedNCT00618241Phase 1
• Pharmacokinetics Study on Nevirapine Resistance in TanzaniaCompletedNCT00294892Phase 2
• The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-infected Pregnant Women.CompletedNCT00145561Phase 1/2